Form C-AR — iMetabolic Biopharma Corporation
0001665160-23-000924 · filed 2023-04-27
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1957114
- Entity
- Corporation
- Jurisdiction
- NV
- Address
- 2155 E Conference Dr
Tempe, AZ 85284-2604 - Phone
- —
Most recent fiscal year financials
View original on SEC EDGAR.